Nuvectis Pharma NVCT
NASDAQ NVCT
$20.70 +0.11 (+0.53%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nuvectis Pharma (NVCT) Preferred Stock Liabilities (2021)

Updated

Nuvectis Pharma (NVCT) reported Preferred Stock Liabilities of $15.25 million for Q4 2021, unchanged from the prior quarter.

Analysis

Nuvectis Pharma (NVCT) Preferred Stock Liabilities (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Nuvectis Pharma 484.66 Mn 370.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 15.25 Mn
Sep 30, 2021 15.25 Mn
Jun 30, 2021 11.23 Mn
API Access

Nuvectis Pharma Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=NVCT&period=max&api_key=YOUR_API_KEY